CORNERSTONE GOVERNMENT AFFAIRS, INC. for VYRIPHARM ENTERPRISES, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 22, 2021 | $30,000 | Replaced |
| 2nd Quarter - Amendment | Jan 20, 2022 | $30,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Policies and regulations associated with testing, tracing and tracking of cannabinoids.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH BISCHOFF | — |
| TONY ESSALIH | COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley) |
Health Issues HCR
Policies and regulations associated with testing, tracing and tracking of cannabinoids.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH BISCHOFF | — |
| TONY ESSALIH | COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley) |
Food Industry (safety, labeling, etc.) FOO
Policies and regulations associated with testing, tracing and tracking of cannabinoids.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH BISCHOFF | — |
| TONY ESSALIH | COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.